ACHE and early-onset autosomal dominant Alzheimer disease: Most therapies approved for Alzheimer’s disease are indicated to only treat the symptoms of Alzheimer’s disease: acetylcholinesterase inhibitors, a glutamatergic modulator (memantine), and an orexin receptor antagonist (suvorexant) for Alzheimer-related insomnia [21,22].